Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.520
-0.050 (-1.95%)
Feb 20, 2026, 3:19 PM EST - Market open
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $97.26 million as of February 20, 2026. Its market cap has decreased by -41.94% in one year.
Market Cap
97.26M
Enterprise Value
601.44K
1-Year Change
-41.94%
Ranking
Category
Stock Price
$2.52
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $97.26M, a decrease of -80.08%. That is a compound annual growth rate of -29.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 99.19M | -12.88% |
| Dec 31, 2025 | 113.85M | -58.58% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | 488.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LENSAR | 139.27M |
| AVITA Medical | 131.72M |
| CVRx, Inc. | 124.72M |
| Treace Medical Concepts | 116.60M |
| Hyperfine | 106.89M |
| Picard Medical | 106.87M |
| Neuronetics | 97.93M |
| Xtant Medical Holdings | 82.67M |